FIELD: medicine.
SUBSTANCE: invention describes method of predicting exacerbations of remitting multiple sclerosis (RMS), where blood is sampled from patients in the period from 6.00 to 9.00 a.m. and indices of NST of monocytes before and after stimulation with pyrogenal are determined, if values of NST-test are higher than 53% and if values of coefficient of NST-test of monocytes activation are lower than 1.5, exacerbation of RMS is predicted.
EFFECT: method is easily reproducible, objective and economical and reduces terms of performing laboratory analyses.
3 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR REMITTENT AND SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS | 2010 |
|
RU2428693C1 |
| METHOD OF PREDICTING STAGE OF MULTIPLE SCLEROSIS TAKING INTO ACCOUNT INDICATORS OF IMMUNOLOGICAL STATUS | 2023 |
|
RU2811481C1 |
| METHOD FOR PREDICTION OF DEVELOPING PROGRESSIVE CLINICAL COURSE OF MULTIPLE SCLEROSIS | 2024 |
|
RU2825506C1 |
| METHOD FOR PREDICTING RECOVERY OF FINE DISMOTILITIES FOLLOWING AGGRAVATION OF MULTIPLE SCLEROSIS | 2013 |
|
RU2545429C1 |
| METHOD FOR DETERMINING PATHOLOGICAL PROCESS ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS | 2016 |
|
RU2613908C1 |
| METHOD OF PATHOLOGICAL PROCESS ACTIVITY DETERMINING IN PATIENTS WITH MULTIPLE SCLEROSIS | 2019 |
|
RU2694614C1 |
| METHOD OF TREATING MULTIPLE SCLEROSIS IN CHILDREN | 2015 |
|
RU2596792C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN GLUCOCORTICOIDS TREATED MULTIPLE SCLEROSIS | 2011 |
|
RU2438133C1 |
| METHOD FOR PREDICTION OF RESPONSE TO THERAPY WITH MULTIPLE SCLEROSIS DISEASE MODIFYING DRUGS OF THE FIRST LINE | 2023 |
|
RU2818847C1 |
| METHOD FOR PREDICTING TRANSFORMATION OF CHRONIC DISSEMINATED ENCEPHALOMYELITIS IN MULTIPLE SCLEROSIS IN CHILDREN | 2020 |
|
RU2740243C1 |
